S
DEAD

Serial Number

90086260

Owner

Hangzhou SoliPharma Co., Ltd.

Attorney

Monica Riva Talley

Filing Date

Jul 31, 2020

Add to watchlist:

No watchlists yet
View on USPTO

S Trademark

Serial Number: 90086260

S is a trademark filed by Hangzhou SoliPharma Co., Ltd. on July 31, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Hangzhou SoliPharma Co., Ltd. (4 trademarks)

260 6th Ave, Bldg 1, 1st F
Hangzhou, Zhejiang 310018 , CN

Entity Type: 99

Trademark Details

Filing Date

July 31, 2020

Registration Date

Not Registered

Published for Opposition

January 19, 2021

Goods & Services

Antibiotics; Collyrium; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, cognitive disorders, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Pharmaceutical preparations for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Biological preparations for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Prescription and non-prescription medicines, namely, injectable pharmaceuticals, pills, tablets, capsules, caplets, liquid drops, sachets, spray, ointment, cream, gel, lotion, patch, inhaler, granule, film, suspension, infusion, suppository and pharmaceutical preparations for the treatment of infectious diseases, immune system related diseases and disorders, respiratory diseases, allergy, pain, digestive system diseases, urinary system diseases, cardiovascular and cerebrovascular diseases, tumors, blood diseases, gynecological diseases, hyperproliferative disease, blood vessel disease, skin disease, obesity, chronic pain and endocrine disease; Drug delivery agents in the form of powders, tablets, capsules, injectable pharmaceuticals, pills, caplets, liquid drops, sachets, spray, ointment, cream, gel, lotion, patch, inhaler, granule, film, suspension, infusion and suppository that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Diagnostic preparations for veterinary purposes; Veterinary preparations, namely, pain relief medication, anti-infective medication, immune disease medication, respiratory disease medication, allergy and pain related medication, digestive system medication, urinary system medication, cardiovascular and cerebrovascular medication, tumor medication, blood disease medication, hyperproliferative disease medication, blood vessel disease medication, skin disease medication, obesity medication, chronic pain medication and endocrine disease medication

Demonstration of goods; Advertising services; online advertising on a computer network; Business management and organization consultancy; Business management consultancy; Business investigations; Professional business consultancy; Import-export agency services; Publication of publicity texts; Commercial information agency services; Market analysis; providing commercial information and advice for consumers in the choice of products and services; Provision of an online marketplace for buyers and sellers of goods and services; Organizing exhibitions for technology for business purposes; Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Pharmaceutical advice; Health counselling; Beauty salon services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Alternative medicine services; Food nutrition consultancy; Health care; Nursing, medical; Medical and pharmaceutical consultation; Telemedicine services; Pharmacists' services to make up prescriptions; Nutritional therapy services; Veterinary services, namely, veterinary assistance; Hygienic and beauty care; Charitable services, namely, providing medical services to underdeveloped countries; Charitable services, namely, providing medical equipment and services to underserved communities

Research and development of new products for others; Scientific research; Chemical analysis; Chemical research; Biological research; Cosmetic research; Medical research; Development of pharmaceutical preparations and medicines; Conducting clinical trials for others, being scientific research; Inspection of medical equipment for quality control purposes; Chemical engineering; Technology consultation in the field of medical research; Research and development of technology in the field of medical research

Filing History

ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Apr 17, 2023 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Apr 17, 2023 ABN4
OPPOSITION TERMINATED NO. 999999
Apr 17, 2023 OP.T
OPPOSITION DISMISSED NO. 999999
Apr 17, 2023 OP.D
OPPOSITION INSTITUTED NO. 999999
May 17, 2021 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 18, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 19, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jan 19, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 30, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 14, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 14, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 14, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 14, 2020 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 14, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 8, 2020 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 23, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 23, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 23, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 23, 2020 CNEA
ASSIGNED TO EXAMINER
Nov 19, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 2, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2020 NWOS
NEW APPLICATION ENTERED
Aug 4, 2020 NWAP